ACR appropriateness criteria® follow-up and retreatment of brain metastases

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 3, 2012, Pages 302-306

  Patel, Samir H ^a   Robbins, Jared R ^c   Gore, Elizabeth M ^d   Bradley, Jeffrey D ^f   Gaspar, Laurie E ^h   Germano, Isabelle ⁱ   Ghafoori, Paiman ^j   Henderson, Mark A ^k   Lutz, Stephen T ^l   McDermott, Michael W ⁿ   Patchell, Roy A ^b   Robins, H Ian ^e   Vassil, Andrew D ^m   Wippold, Franz J ^g   Videtic, Gregory M ^m  

^a MAYO CLINIC   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

^f MO   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j DUKE UNIVERSITY   (United States)

^k INDIANA UNIVERSITY   (United States)

^l Blanchard Valley Regional Cancer Center   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

appropriateness criteria; brain metastases; radiation therapy; radiosurgery; recurrence

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GEFITINIB; LAPATINIB; PACLITAXEL; TEMOZOLOMIDE; TOPOTECAN;

BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DELPHI STUDY; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NEUROIMAGING; PEER REVIEW; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; RETREATMENT; REVIEW; STEREOTACTIC RADIOSURGERY;

BRAIN NEOPLASMS; DELIVERY OF HEALTH CARE; FOLLOW-UP STUDIES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RETREATMENT;

EID: 84861487688     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31824be246     Document Type: Review

References (33)

1. Mehta MP, Patel RR. Radiotherapy and radiosurgery for brain metastases. In: Black PM, Loeffler JS., eds. Cancer of the Nervous System. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 2005:657-672
2. Mamon HJ, Yeap BY, Janne PA, et al. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005;23:1530-1537
3. Tan TC, Black PM. Surgery for brain metastases. In: Black PM, Loeffler JS, eds. Cancer of the Nervous System. 2nd ed Philadelphia: Lippincott, Williams and Wilkins; 2005: 645-656
4. Pollock BE, Brown PD, Foote RL, et al. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol. 2003;61: 73-80
5. Varlotto JM, Flickinger JC, Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003;57:452-464
6. Chao ST, Barnett GH, Liu SW, et al. Five-year survivors of brain metastases: a single-institution report of 32 patients. Int J Radiat Oncol Biol Phys. 2006;66:801-809
7. Sadikov E, Bezjak A, Yi QL, et al. Value of whole brain reirradiation for brain metastases-single centre experience. Clin Oncol (R Coll Radiol). 2007;19:532-538
8. Chao ST, Barnett GH, Vogelbaum MA, et al. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer. 2008;113:2198-2204
9. Noel G, Medioni J, Valery CA, et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer. 2003;41:333-343
10. Kwon KY, Kong DS, Lee JI, et al. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg. 2007;109:132-137
11. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005;63:37-46
12. Roberge D, Souhami L. Tumor bed radiosurgery following resection of brain metastases: a review. Technol Cancer Res Treat. 2010;9:597-602
13. Vecil GG, Suki D, Maldaun MV, et al. Resection of brain metastases previously treated with stereotactic radiosurgery J Neurosurg. 2005;102:209-215
14. Truong MT St, Clair EG, Donahue BR, et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery. 2006;59:86-97; discussion 86-97
15. Kano H, Kondziolka D, Zorro O, et al. The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg 2009;111:825-831
16. Schuette W. Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer. 2004;45(Suppl 2): S253-S257
17. Wong ET, Berkenblit A. The role of topotecan in the treatment of brain metastases. Oncologist. 2004;9:68-79
18. Kopf B, De Giorgi U, Zago S, et al. Innovative therapy for patients with brain metastases: oral treatments. J Chemother. 2004; 16(suppl 5):94-97
19. Hotta K, Kiura K, Ueoka H, et al. Effect of gefitinib ("Iressa", ZD1839) on brain metastases in patients with adVanced non-smallcell lung cancer. Lung Cancer. 2004;46:255-261
20. Sutherland S, Ashley S, Miles D, et al. Treatment of HER2- positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases-the UK experience. Br J Cancer. 2010;102: 995-1002
21. De Braganca KC, Janjigian YY, Azzoli CG, et al. Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer. J Neurooncol. 2010;100:443-447
22. Sheehan JP, Yen CP, Nguyen J, et al. Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article. J Neurosurg. 2011; 114:763-768
23. Belohlavek O, Simonova G, Kantorova I, et al. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med Mol Imaging. 2003;30:96-100
24. Tsuyuguchi N, Sunada I, Iwai Y, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg. 2003;98:1056-1064
25. Wang SX, Boethius J, Ericson K. FDG-PET on irradiated brain tumor: ten years' summary. Acta Radiol. 2006;47:85-90
26. Ross DA, Sandler HM, Balter JM, et al. Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol. 2002;56:175-181
27. Essig M, Waschkies M, Wenz F, et al. Assessment of brain metastases with dynamic susceptibility-weighted contrastenhanced MR imaging: initial results. Radiology. 2003;228: 193-199
28. Hoefnagels FW, Lagerwaard FJ, Sanchez E, et al. Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol. 2009;256:878-887
29. Mitsuya K, Nakasu Y, Horiguchi S, et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2010;99: 81-88
30. Kamath R, Ryken TC, Meeks SL, et al. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005;61:1467-1472
31. Koutras AK, Marangos M, Kourelis T, et al. Surgical management of cerebral metastases from non-small cell lung cancer. Tumori 2003;89:292-297
32. Noel G, Proudhom MA, Valery CA, et al. Radiosurgery for reirradiation of brain metastasis: results in 54 patients. Radiother Oncol. 2001;60:61-67
33. Sheehan J, Kondziolka D, Flickinger J, et al. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg. 2005;102(suppl):247-254